4//SEC Filing
Jayne David R.W. 4
Accession 0001600620-24-000074
CIK 0001600620other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:11 PM ET
Size
4.6 KB
Accession
0001600620-24-000074
Insider Transaction Report
Form 4
Jayne David R.W.
Director
Transactions
- Sale
Common Stock
2024-05-21$5.74/sh−4,946$28,390→ 44,364 total
Footnotes (1)
- [F1]Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on May 19, 2023.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001838242
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 4:11 PM ET
- Size
- 4.6 KB